|Articles|January 1, 2003

More evidence that thimerosal in vaccines is no hazard

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Weekly review: Centanafadine NDA, gene therapy approval, and more

ByJoshua Fitch, Senior Editor

November 30th 2025

Navepegritide demonstrates growth velocity, skeletal alignment in children with achondroplasia

ByMorgan Ebert, Managing Editor

November 29th 2025

Jonathan Flyer, MD, outlines strategies to boost pediatric lipid screenings

ByJonathan N. Flyer, MD

November 28th 2025

Thao Ly-Phan, MD, discusses how an integrated obesity care model can strengthen family engagement

ByThao-Ly Phan, MD, MPH

November 28th 2025

Parents weigh holiday traditions against COVID-19 risks, national poll shows

ByMorgan Ebert, Managing Editor

November 27th 2025

Latest CME

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Multimedia

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Multimedia

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

More evidence that thimerosal in vaccines is no hazard

Newsletter

Related Content

Weekly review: Centanafadine NDA, gene therapy approval, and more

Navepegritide demonstrates growth velocity, skeletal alignment in children with achondroplasia

Jonathan Flyer, MD, outlines strategies to boost pediatric lipid screenings

Thao Ly-Phan, MD, discusses how an integrated obesity care model can strengthen family engagement

Parents weigh holiday traditions against COVID-19 risks, national poll shows

Latest CME

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Navepegritide demonstrates growth velocity, skeletal alignment in children with achondroplasia

Parents weigh holiday traditions against COVID-19 risks, national poll shows

Weekly review: Centanafadine NDA, gene therapy approval, and more

Thao Ly-Phan, MD, discusses how an integrated obesity care model can strengthen family engagement

Jonathan Flyer, MD, outlines strategies to boost pediatric lipid screenings